stockrowAbCellera Biologics Inc. (ABCL) vs Xenon Pharmaceuticals Inc. (XENE)
- AbCellera Biologics Inc. ABCL 11.89 +6.83%
- Xenon Pharmaceuticals Inc. XENE 39.00 +3.50%
AbCellera Biologics Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. AbCellera Biologics Inc. and Xenon Pharmaceuticals Inc. are of similar size ($3.7B and $3.6B). AbCellera Biologics Inc. grew revenue faster over the last twelve months: 101.3% against −8.15%. Xenon Pharmaceuticals Inc. has the higher net margin (0.00% vs −248.8%) and the lower return on invested capital (−88.5% vs −42.5%). Across the 17 metrics below, AbCellera Biologics Inc. leads on 10 and Xenon Pharmaceuticals Inc. on 7.
Valuation
Profitability
| Metric | ABCL | XENE | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 28.40% | 65.16% |
| Operating margin | (340.25%) | 0.00% | 0.00% |
| Net margin | (248.82%) | 0.00% | 0.00% |
| Free cash flow margin | (180.84%) | 0.00% | 0.00% |
| Return on equity | (17.30%) | (43.62%) | (50.12%) |
| Return on assets | (12.15%) | (41.54%) | (45.60%) |
| Return on invested capital | (42.52%) | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack